Overview

Long-term Safety and Tolerability of BHV-7000

Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Phase:
PHASE2
Details
Lead Sponsor:
Biohaven Therapeutics Ltd.